Background and Objective: Anxiety in pregnancy has severe complications for a mother and her developing baby. Despite this fact, few studies have been done about antenatal anxiety and its risk factors, so this research aimed to explore components and dimensions of this kind of anxiety.
Methods: This qualitative study was conducted in Tehran city from May 2016 to December 2017. The participants were twenty-eight pregnant women who referred to health care services. In order to collect data, purposive sampling and face-to-face semi-structured in-depth interviews were used. Data were analyzed simultaneously with data collection using qualitative content analysis with a conventional approach. 
Results: Mothers from different social backgrounds, educational levels and ethnicities, aged 18-41 years old participated in this study and after analysis, mothers’ perceptions of anxiety-provoking factors were classified into nine domains: including lack of information and planning, mothers’ loss of well-being, conflict with spouse, sociocultural issues, financial problems, parental challenges, healthcare related, fetal health and lack of support.
Conclusion: With respect to what was found in this study, it seems that identification and screening of vulnerable mothers would be a dramatic help for the timely prevention and control of this mental health disorder and its complications.
Keywords: Pregnancy anxiety; Antenatal anxiety, Maternal anxiety, Parenting anxiety


» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7620
ACE 17 Purecontrol FGAir Jordan

Current Issue

Volume 13, Issue 1, January-March 2021

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.


To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


 The  most recent editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: